Innovations and Growth Opportunities in Microfluidics, Point of Care Diagnostics and Digital Health: Including Microfluidic-Based Point-Of-Care Diagnostics, Diagnostic Biochips & More - ResearchAndMarkets.com
09 Dec 2022
Diagnostic Reagents
DUBLIN--(BUSINESS WIRE)--The "Innovations and Growth Opportunities in Microfluidics, Point of Care Diagnostics and Digital Health" report has been added to ResearchAndMarkets.com's offering.
'Innovations and Growth Opportunities in Microfluidics, Point of Care Diagnostics and Digital Health'
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The issue includes advanced diagnostic technologies such as microfluidic-based point-of-care diagnostics, diagnostic biochips, AI-enabled breast cancer, and stroke diagnosis, genomic test for melanoma, or sticker based pediatric cystic fibrosis diagnosis.
Some of the advanced medical device technologies such as nano-pulse stimulation technology, retinal prosthesis system, dry powder nebulizer, and nanotechnology-based blood purification system have been covered in this issue. Digital health solutions such as digital therapeutics for chronic condition management, digital colposcope, and AI in imaging are also included in this issue. These innovations portray the diversity in their technology readiness levels, indicating an immediate or potential market impact. The growth opportunities for all these advanced medical device technologies are also covered in this issue.
The Advanced MedTech TOE analyzes and reports new and emerging technologies; advances in R&D, product development, and regulatory matters specifically related to the areas of wearables, implantables, diagnostics, surgical tools and instrumentation, image-guided surgery, drug delivery, patient monitoring, digital health, and medical imaging. Medical devices and imaging technology and innovation research cover cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Medical devices and imaging technology and innovation research cover cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms.
Medical devices and imaging technology and innovation research cover cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms.
Key Topics Covered:
1. Innovations in Medical Devices and Imaging
Thermoplastic Elastomer for Biomicrofluidic Devices
Value Proposition of Eden Tech
Eden Tech - Investor Dashboard
Microfluidics-based Point-of-care (POC) Blood Coagulation Diagnostics
Value Proposition of Enzyre
Enzyre - Investor Dashboard
Epigenetic Clock Technology for Health and Aging Measurement
Value Proposition of FOXO Technologies
FOXO Technologies - Investor Dashboard
Non-invasive Genomic Analysis Test for Melanoma
Value Proposition of Akonni Biosystems
Akonni Biosystems - Investor Dashboard
Microfluidic Protein Microarray-based Point-of-care Diagnostics
Sanwa BioTech's Value Proposition
Sanwa BioTech - Investor Dashboard
High-fidelity Implantable Neural Probes
Diagnostic Biochips' Value Proposition
Diagnostic Biochips - Investor Dashboard
Indoor Positioning Platform for Providing Seamless Navigation for Patients
Pointr Limited's Value Proposition
Pointr Limited - Investor Dashboard
Digital Therapeutics Platform for Managing Chronic Conditions
Sidekick Health's Value Proposition
Sidekick Health - Investor Dashboard
Wristband for Menopausal Hot Flashes Management
Embr Labs Inc.'s Value Proposition
Embr Labs Inc. - Investor Dashboard
Nano-pulse Stimulation Technology for Treating Benign Lesions
Pulse Biosciences Inc.'s Value Proposition
Pulse Biosciences Inc. - Investor Dashboard
Digital Therapeutic Platform Treating Chronic Fecal Incontinence in Women
Renovia - Value Proposition
Renovia - Investor Dashboard
Retinal Prostheses System for Providing Artificial Vision to Patients
Pixium Vision - Value Proposition
Pixium Vision - Investor Dashboard
Digital Colposcope for Point-of-Care Cervical Cancer Detection
Biop Medical's Value Proposition
Biop Medical - Investor Dashboard
Artificial Intelligence (AI)-powered Software for Early Diagnosis of Stroke
Cerebra AI's Value Proposition
Cerebra AI - Investor Dashboard
Dry Powder Nebulizer for Lower Respiratory Tract Infection Treatment
NHT's Value Proposition
NHT - Investor Dashboard
Nanotechnology-based Blood Purification System for Toxin Removal
hemotune's Value Proposition
hemotune - Investor Dashboard
University of Thessaly - Value Proposition
AI System for Improving Accuracy of Breast Cancer Diagnosis in Ultrasound Images
New York University Abu Dhabi - Value Proposition
2. Key Contacts
3. Appendix
Criteria for Rating of Innovations - Explanation
Companies Mentioned
Cerebra AI
hemotune
New York University Abu Dhabi
NHT
Pixium Vision
Pointr Limited
Renovia
Sidekick Health
For more information about this report visit https://www.researchandmarkets.com/r/qh8hfe
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.